Nihel Khoudour Selected Research

Nihel Khoudour Research Topics

5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 11/2019
3	Neoplasms (Cancer) 05/2021 - 01/2021
2	Vasculitis (Vasculitides) 11/2023 - 03/2021
2	Critical Illness (Critically Ill) 01/2022 - 01/2016
2	Lung Neoplasms (Lung Cancer) 01/2020 - 11/2019
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 11/2023
1	Cushing Syndrome 05/2023
1	Infections 01/2023
1	Cardiotoxicity 01/2023
1	Sarcoma (Soft Tissue Sarcoma) 06/2022
1	Poisoning 03/2022
1	Paralysis (Palsy) 03/2022
1	Sepsis (Septicemia) 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 08/2021
1	Fibrosarcoma 01/2021
1	Melanoma (Melanoma, Malignant) 04/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2017

3	NivolumabIBA 03/2021 - 11/2019
2	Rituximab (Mabthera)FDA Link 11/2023 - 03/2021
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 09/2022 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2016
2	Immunoglobulins (Immunoglobulin)IBA 05/2021 - 03/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2023
1	OsilodrostatIBA 05/2023
1	Metyrapone FDA Link 05/2023
1	CrizotinibIBA 01/2023
1	SofosbuvirIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	velpatasvirIBA 01/2023
1	osimertinibIBA 09/2022
1	pazopanib FDA Link 06/2022
1	Angiogenesis InhibitorsIBA 06/2022
1	Serotonin (5 Hydroxytryptamine)IBA 03/2022
1	Cyproheptadine (Periactin)FDA Link 03/2022
1	Tramadol (K315)FDA LinkGeneric 03/2022
1	Amikacin (A.M.K)FDA LinkGeneric 01/2022
1	olaparibIBA 08/2021
1	pembrolizumabIBA 05/2021
1	Immune Checkpoint InhibitorsIBA 03/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	dabrafenibIBA 04/2020
1	trametinibIBA 04/2020
1	LigandsIBA 02/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2020
1	CD40 Ligand (CD40L)IBA 02/2020
1	Androgen Receptors (Androgen Receptor)IBA 01/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020
1	enzalutamideIBA 01/2020
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2017
1	Atovaquone (Mepron)FDA Link 01/2017
1	Valacyclovir (Valtrex)FDA LinkGeneric 01/2017
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017

3	Therapeutics 11/2023 - 02/2020
1	Extracorporeal Membrane Oxygenation 01/2022
1	Castration 01/2020